Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Dental Abscess : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Peritonsillar Abscess




Patient Education
Teeth and Mouth Center

Infections Center

Dental Abscess Overview

Dental Abscess Causes

Dental Abscess Symptoms

Dental Abscess Treatment

Toothache Overview

When to Visit the Dentist - Introduction

Antibiotics Introduction




Author: Karen Schneider, MD, Assistant Professor, Department of Pediatrics, Division of Pediatric Emergency Medicine, Johns Hopkins University School of Medicine

Karen Schneider is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and American Medical Association

Editors: Halim Hennes, MD, MS, Pediatric Emergency Medicine Research Director, Professor, Departments of Pediatrics and Emergency Medicine, Medical College of Wisconsin; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine; Wayne Wolfram, MD, MPH, Clinical Associate Professor, Departments of Pediatrics, Children's Hospital and University of Cincinnati; Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine; Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: dental abscess, odontogenic abscess, tooth abscess, dentoalveolar abscess, periapical abscess, periodontal abscess, pericoronitis, tooth infection, infected tooth, dental caries, pulpitis, baby-bottle tooth decay, BBTD, Ludwig angina, Ludwig's angina, simple dentoalveolar abscess, odontogenic infection, pulpitides, early-childhood caries, caries, gingivitis, plaque

Background

A dentoalveolar abscess is an acute lesion characterized by localization of pus in the structures that surround the teeth. Most patients are treated easily with analgesia, antibiotics, drainage, and/or referral to a dentist or oral-maxillofacial surgeon. However, the physician should be aware of potential complications of simple dentoalveolar abscess.

Pathophysiology

The term dentoalveolar abscess comprises 3 distinct processes, as follows:

  • A periapical abscess that originates in the dental pulp and is usually secondary to dental caries is the most common dental abscess in children. Dental caries erode the protective layers of the tooth (ie, enamel, dentin) and allow bacteria to invade the pulp, producing a pulpitis. Pulpitis can progress to necrosis, with bacterial invasion of the alveolar bone, causing an abscess.
  • A periodontal abscess involves the supporting structures of the teeth (periodontal ligaments, alveolar bone). This is the most common dental abscess in adults but may occur in children with impaction of a foreign body in the gingiva.
  • Pericoronitis describes the infection of the gum that overlies a partially erupted third molar.

Odontogenic infections are polymicrobial, with an average of 4-6 different causative bacteria. The dominant isolates are strictly anaerobic gram-negative rods and gram-positive cocci, in addition to facultative and microaerophilic streptococci. Anaerobic bacteria outnumber aerobes 2-3:1.1 In general, strictly anaerobic gram-negative rods are more pathogenic than facultative or strictly anaerobic gram-positive cocci.

Generally, a nonpathologic resident bacterium gains entry when the host's defenses are breached, rather than when a nontypical microorganism is introduced. The predominant species include those of Bacteroides, Fusobacterium, Peptococcus, and Peptostreptococcus, as well as Streptococcus viridans.

Mortality/Morbidity

Mortality is rare and is usually due to airway compromise. Morbidity relates to pain, probable tooth loss, and dehydration. See Complications.

Race

No race predilection is observed.

Sex

No sex predilection is noted.

Age

  • Dental abscess is rare in infants because abscesses do not form until teeth erupt.
  • In children, periapical abscess is the most common type of dental abscess. This is because of the combination of poor hygiene, thinner enamel, and the primary dentition having more abundant blood supply, which allows for an increased inflammatory response.
  • In adults, periodontal abscess is more common than periapical abscess.



History

  • Localized pain and swelling (may progress over a few hours to days)
  • Thermal sensitivity (periapical abscess)
  • Fever
  • Gingival bleeding (on occasion with periodontal abscess)

Physical

  • Gingiva
    • Swelling
    • Warmth
    • Erythema
    • Fluctuant mass that usually extends toward the buccal side of the gum and to the gingival-buccal reflection
  • Teeth: The tooth that is most frequently involved is the lower third molar, followed by other lower posterior teeth; upper posterior teeth are involved much less frequently, and anterior teeth are rarely involved.
    • Increased mobility (mostly periapical abscess)
    • Pressure or percussion tenderness (mostly periapical abscess)
    • Extrusion
  • Regional lymph node involvement
  • More severe infection
    • Trismus
    • Difficulty swallowing (dysphagia)
    • Respiratory difficulty
  • Neck or facial swelling (see Complications)

Causes

  • Pulpitides are dental caries caused by the following:
    • Baby-bottle tooth decay (BBTD): Early-childhood caries is replacing this term because the description also includes dental caries in breastfed babies.
    • Plaque: This is a precipitate of denatured salivary proteins that allow bacteria to adhere to the enamel of teeth.
  • In immunocompromised patients, bacteria may hematogenously spread to invade the pulp of the tooth.
  • Gingivitis is an inflammation of the gingiva.
  • Posttraumatic infection or postsurgical infection may also cause dental abscess.



Peritonsillar Abscess

Other Problems to be Considered

Gingivostomatitis
Parotiditis
Facial cellulitises
Neoplasms



Lab Studies

  • Uncomplicated (ie, simple) abscess: No laboratory studies are required.
  • Complicated abscess (accompanying cellulitis)
    • The CBC count may reveal leukocytosis with neutrophil predominance.
    • Obtain a blood culture (aerobic and anaerobic) before initiating parenteral antibiotics.
    • Needle aspirate is indicated for Gram stain and culture.

Imaging Studies

  • Depending on severity of abscess based on clinical presentation the following is recommended:
    • Periapical radiography is the first level of investigation. It provides a localized view of the tooth and its supporting structures.
    • Panoramic radiography (pantomography) is most helpful in emergency situations because it provides the most information for all teeth and supporting structures.
  • If cellulitis swelling extends beyond local area then the following is indicated:
    • Lateral and anteroposterior neck views may reveal a soft tissue neck mass that impinges on the airway.
    • CT scanning with intravenous contrast is the most accurate method to determine the location, size, extent, and relationship of the inflammatory process to the surrounding vital structures.

Procedures

  • Aspiration
    • Confirm presence of the abscess via needle aspiration.
    • If pus is obtained, do not aspirate more than 1 or 2 drops. Leave the abscess as large as possible to make the area easier to find for further management.
    • If pus cannot be aspirated, manage medically until a more localized infection develops.
  • Incision and drainage may be performed only if pus can be aspirated.
  • Packing a periapical abscess is generally not necessary.

Histologic Findings

The flora at different oral sites varies. Anaerobes usually outnumber aerobes and facultative anaerobes. Most odontogenic infections involve plaque organisms. Supragingival plaque consists mainly of gram-positive facultative anaerobes or microaerophilic cocci and rods. Subgingival plaque consists of anaerobic gram-negative rods with motile form, including spirochetes.



Medical Care

  • Assess the airway upon respiratory distress, oropharyngeal tissue swelling, or inability to handle secretions; then, secure the airway via endotracheal intubation or tracheostomy.
  • Properly collect specimen for Gram stain and culture.
  • Administer empiric antibiotic therapy.
  • Administer analgesia.
  • Hydrate the patient.

Surgical Care

  • The primary therapeutic modality is surgical drainage of any pus collection. Incision and drainage or spontaneous rupture of the abscess quickly accelerates resolution of the infection.
  • Emergent surgery is indicated in the operating room if the airway is threatened or if the patient's condition is rapidly deteriorating.

Consultations

  • Consult a dentist if the patient has an uncomplicated abscess.
  • Consult a maxillofacial oral surgeon if the patient has a complicated abscess.

Diet

Diet is as tolerated. However, a soft bland diet is usually preferred.

Activity

Activity is as tolerated.



When drainage cannot be achieved or the patient shows signs of systemic involvement, antibiotic therapy is indicated; in addition, an increasing number of immunocompromised patients require antibiotic therapy.

Drug Category: Antibiotics

Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting.

Drug NamePenicillin (Pfizerpen, Pen-Vee K, Beepen-VK)
DescriptionDOC; effective against most aerobes and anaerobes. Penicillin has traditionally been considered the DOC for odontogenic infections. The efficacy of penicillin is a concern because of the emergence of beta-lactamaseproducing organisms, which confer resistance to penicillins. Penicillin still remains the antibiotic of choice for mild-to-moderate infections.
Inhibits the biosynthesis of cell wall mucopeptide. Bactericidal against sensitive organisms when adequate concentrations are reached and most effective during the stage of active multiplication. Inadequate concentrations may produce only bacteriostatic effects. Penicillin V (phenoxymethyl penicillin) is administered orally, whereas aqueous penicillin G is administered IV or IM.
Adult DosePenicillin V: 250-500 mg PO q6-8h
Penicillin G: 2-24 million U/d IV/IM divided q4-6h
Pediatric DosePenicillin V: 15-62.5 mg/kg/d (25,000-100,000 U/kg/d) PO divided q4-8h
Penicillin G: 100,000-400,000 U/kg/d divided q4-6h; not to exceed 24 million U/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid can increase effects of penicillin; coadministration of tetracyclines can decrease effects of penicillin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in impaired renal function

Drug NameAzithromycin (Zithromax)
DescriptionActs by binding to 50S ribosomal subunit of susceptible microorganisms and blocks dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Nucleic acid synthesis is not affected. Concentrates in phagocytes and fibroblasts, as demonstrated by in vitro incubation techniques. In vivo studies suggest that concentration in phagocytes may contribute to drug distribution to inflamed tissues. Treats mild-to-moderate microbial infections.
Adult DoseDay 1: 500 mg PO
Days 2-5: 250 mg/d PO
Alternatively, 1 g PO once
Pediatric Dose<6 months: Not established
>6 months:
Day 1: 10 mg/kg PO once; not to exceed 500 mg/d
Days 2-5: 5 mg/kg/d PO; not to exceed 250 mg/d
ContraindicationsDocumented hypersensitivity; hepatic impairment; do not administer with pimozide
InteractionsMay increase toxicity of theophylline, warfarin, and digoxin; effects are reduced with coadministration of aluminum or magnesium antacids; nephrotoxicity and neurotoxicity may occur when coadministered with cyclosporine
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsSite reactions can occur with IV route; bacterial or fungal overgrowth may result from prolonged antibiotic use; may increase hepatic enzymes and cholestatic jaundice; caution in patients with impaired hepatic function, prolonged QT intervals, or pneumonia; caution in patients who are hospitalized, geriatric, or debilitated

Drug NameMetronidazole (Flagyl)
DescriptionEffective against only obligate anaerobes. Alternative for patients who are allergic to penicillin. Consider the combination of penicillin with metronidazole because metronidazole compensates for limited activity of penicillin against beta-lactamaseproducing stains of anaerobes. Compliance must be considered with a 2-drug regimen.
Adult DoseLoading dose: 15 mg/kg or 1 g for a 70-kg adult IV over 1 h
Maintenance dose: 6 h following loading dose, administer 7.5 mg/kg or 500 mg for a 70-kg adult IV over 1 h q6-8h; not to exceed 4 g/d
Pediatric Dose30 mg/kg/d PO/IV divided q6h; not to exceed 4 g/d
ContraindicationsDocumented hypersensitivity; first trimester of pregnancy
InteractionsCimetidine may increase toxicity of metronidazole; may increase effects of anticoagulants; may increase toxicity of lithium and phenytoin; disulfiramlike reaction may occur with orally ingested ethanol
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy

Drug NameClindamycin (Cleocin)
DescriptionConsidered by many as first-line therapy because of emergent penicillin resistance. Excellent activity against oral aerobes and anaerobes; penetrates bone and abscess cavities, but its use is limited because of the danger of inducing pseudomembranous colitis; no more effective than penicillin against anaerobes. Use in patients who are allergic to penicillin.
Adult Dose150-450 mg PO q6-8h; not to exceed 1.8 g/d
600-1200 mg/d IV/IM divided q6-8h
Pediatric Dose20-30 mg/kg/d PO divided q6h; not to exceed 1.8 g/d
25-40 mg/kg/d IV/IM divided q6-8h
ContraindicationsDocumented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis

Drug NameAmoxicillin and clavulanate (Augmentin)
DescriptionAmoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Addition of clavulanate inhibits beta-lactamaseproducing bacteria. Good alternative antibiotic for patients allergic or intolerant to the macrolide class. Is usually well tolerated and provides good coverage to most infectious agents. Not effective against Mycoplasma and Legionella species. The half-life of oral dosage form is 1-1.3 h. Has good tissue penetration but does not enter cerebrospinal fluid.
For children aged 3 mo or older, base dosing protocol on amoxicillin content. Because of different amoxicillin/clavulanic acid ratios in 250-mg tab (250/125) vs 250-mg chewable tab (250/62.5), do not use 250-mg tab until child weighs >40 kg.
Adult Dose500 mg PO tid for 7-10 d
Pediatric Dose<3 months: 125 mg/5mL PO susp; 30 mg/kg/d (based on amoxicillin component) PO divided bid for 7-10 d
>3 months: if using 200 mg/5 mL or 400 mg/5 mL susp, 45 mg/kg/d PO q12h; if using 125 mg/5 mL or 250 mg/5 mL susp, 40 mg/kg/d PO q8h for 7-10 d
>40 kg: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with warfarin or heparin increases risk of bleeding; may act synergistically against selected microorganisms when coadministered with aminoglycosides; coadministration with allopurinol may increase incidence of amoxicillin rash; may decrease efficacy of oral contraceptives when administered concomitantly
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in renal impairment; diarrhea may occur; cross-allergy may occur with other beta-lactams and cephalosporins

Drug NameCefoxitin (Mefoxin)
DescriptionSecond-generation cephalosporin with activity against some gram-positive cocci, gram-negative rod infections, and anaerobic bacteria. Inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins; inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death.
Infections caused by cephalosporin- or penicillin-resistant gram-negative bacteria may respond to cefoxitin.
Adult Dose2 g IV q6h and 100 mg IV doxycycline q12h; continue at least 4 d and at least 48 h after improvement; then, 100 mg PO doxycycline bid 10-14 d
Pediatric Dose80-160 mg/kg/d IV/IM divided q4-8h; not to exceed 12 g/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase effects of cefoxitin; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function)
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in severe renal insufficiency (high doses may cause CNS toxicity); superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy

Drug NameMoxifloxacin (Avelox)
DescriptionInhibits the A subunits of DNA gyrase, resulting in inhibition of bacterial DNA replication and transcription.
Adult Dose400 mg/d PO/IV
Pediatric Dose<18 years: Not recommended
>18 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; known Q-T prolongation, concurrent administration of drugs that cause Q-T prolongation
InteractionsAntacids and electrolyte supplements reduce absorption; loop diuretics, probenecid, cimetidine increase serum levels; NSAIDs enhance CNS-stimulating effect; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT); ferrous sulfate decreases bioavailability (administer moxifloxacin 4 h prior to or 8 h following ferrous sulfate); coadministration with drugs that prolong QTc interval (quinidine, procainamide, amiodarone, sotalol, erythromycin, tricyclic antidepressants) increase risk of life-threatening arrhythmia
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsIn prolonged therapy, periodically evaluate organ-system functions (eg, renal, hepatic, hematopoietic); superinfections may occur with prolonged or repeated antibiotic therapy; fluoroquinolones have induced seizures in patients with CNS disorders and have caused tendinitis or tendon rupture



Further Inpatient Care

  • Criteria for hospital admission include the following:
    • Unable to handle secretions
    • Airway compromise
    • Involvement of facial spaces of head and neck
    • Systemic involvement
    • Failure of outpatient therapy

Further Outpatient Care

  • Follow-up care should be obtained as recommended by a physician.

Deterrence/Prevention

  • The most effective preventive measure against dental caries and, thus, dentoalveolar abscess is fluoridation of communal drinking water.
  • In fluoride-deficient areas, prevention can be obtained with dietary fluoride supplements. The American Academy of Pediatrics and the American Dental Association recommend administration of fluoride if the concentration of fluoride in the drinking water is less than 0.3 parts per million (ppm). Administer fluoride according to the following age-appropriate schedule (all doses are per day):
    • Age birth to 6 months - 0 mg
    • Age 6 months to 3 years - 0.25 mg
    • Age 3-6 years - 0.5 mg
    • Age 6-16 years - 1 mg
  • The other effective preventive measure against dental caries and dentoalveolar abscess is proper dental hygiene. This includes brushing teeth after meals and regular dental check-ups.

Complications

  • Dentocutaneous fistulae arise from chronic dental infections. The fistulous pathway develops as the chronic inflammation erodes through the alveolar bone, perforates the periosteum, and spreads into the surrounding soft tissues. The diagnosis is often missed because a chronic asymptomatic dental infection is usually present and the skin lesion is mistakenly thought to arise locally.
  • Osteomyelitis was common before the era of antibiotic therapy. Osteomyelitis is an inflammation of the medullary cavity and adjacent cortex of bone. The mandible is more commonly involved than the maxilla because the maxilla has a better blood supply.
  • Cavernous sinus thrombosis (CST) may be a complication. Approximately 10% of patients with CST have an odontogenic focus. Spread of infection from dental abscesses to the cavernous sinus is believed to occur via the valveless pterygoid venous plexus by way of the retromandibular vein. Patients often present with headache, unilateral retro-orbital pain, periorbital edema, fever, proptosis, chemosis, and ptosis. Treatment consists of antibiotics, anticoagulants, and, occasionally, surgery.
  • Ludwig angina is an infection of the submandibular region. Abscesses of the second and third mandibular molars may perforate the mandible and spread into the submandibular and submental spaces. Ludwig angina is manifest by swelling of the floor of the mouth and elevation and posterior displacement of the tongue. A rapidly spreading gangrenous cellulitis produces a brawny edema of the suprahyoid region of the neck. The infection begins unilaterally but quickly spreads to include the entire neck. The most common presenting symptoms are oral, neck, and dental pain; neck swelling; odynophagia; dysphagia; dysphonia; trismus; and tongue swelling. Airway patency is the main concern. Ludwig angina is unusual in children.
  • Maxillary sinusitis may occur from direct extension of an odontogenic infection or from perforation of the floor of the sinus during extraction.
  • Facial-space swelling most often involves the following areas:
    • Submandibular swelling is caused by dental abscesses from the second or third molars. A firm, ill-defined, and often significant-sized swelling is present below the mandible. The inferior border and angle of the mandible are difficult to palpate.
    • Sublingual swelling is caused by any lower tooth whose apex is above the mylohyoid muscle attachment (ie, incisors, canines, premolars, mesial roots of the first molar). Infections produce a unilateral elevation of the floor of the mouth near the offending tooth but can spread across the midline, causing pain, dysphagia, and an elevation of the base of the tongue, leading to potential airway compromise.
    • Buccal swelling originates from infected maxillary or mandibular molars. Clinically, infection produces a large tender swelling of the cheek without trismus. Boundaries for this type of infection may extend from the philtrum of the lip, to the border of the parotid, and up to the eye.
    • Less frequently involved facial-space swellings include submental, masticator, canine, lateral pharyngeal, and retropharyngeal.

Prognosis

  • The prognosis is excellent with proper incision, drainage, antibiotic therapy, tooth extraction, root canal therapy and follow-up care.

Patient Education



Medical/Legal Pitfalls

  • Failure to consult a dentist if the patient has an uncomplicated abscess
  • Failure to consult a maxillofacial oral surgeon if the patient has a complicated abscess



Media file 1:  Obvious swelling of the right cheek.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Side view. Fluctuant mass extending toward the buccal side of the gum end to the gingival-buccal reflection.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Gingiva with swelling and erythema.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  1. Stefanopoulos PK, Kolokotronis AE. The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Oct 2004;98(4):398-408. [Medline].
  2. Ferrera PC, Busino LJ, Snyder HS. Uncommon complications of odontogenic infections. Am J Emerg Med. May 1996;14(3):317-22. [Medline].
  3. Flynn TR, Shanti RM, Levi MH, et al. Severe odontogenic infections, part 1: prospective report. J Oral Maxillofac Surg. Jul 2006;64(7):1093-103. [Medline].
  4. Gill Y, Scully C. The microbiology and management of acute dentoalveolar abscess: views of British oral and maxillofacial surgeons. Br J Oral Maxillofac Surg. Dec 1988;26(6):452-7. [Medline].
  5. Hall V, Collins MD, Hutson RA, et al. Actinomyces oricola sp. nov., from a human dental abscess. Int J Syst Evol Microbiol. Sep 2003;53(Pt 5):1515-8. [Medline][Full Text].
  6. LeJeune HB, Amedee RG. A review of odontogenic infections. J La State Med Soc. Jun 1994;146(6):239-41. [Medline].
  7. Lewis MA, MacFarlane TW, McGowan DA. A microbiological and clinical review of the acute dentoalveolar abscess. Br J Oral Maxillofac Surg. Dec 1990;28(6):359-66. [Medline].
  8. Lewis MA, MacFarlane TW, McGowan DA. Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses. J Antimicrob Chemother. Jan 1989;23(1):69-77. [Medline].
  9. Pynn BR, Sands T, Pharoah MJ. Odontogenic infections: Part one. Anatomy and radiology. Oral Health. May 1995;85(5):7-10, 13-4, 17-8 passim. [Medline].
  10. Sands T, Pynn BR, Katsikeris N. Odontogenic infections: Part two. Microbiology, antibiotics and management. Oral Health. Jun 1995;85(6):11-4, 17-21, 23 passim. [Medline].

Dental Abscess excerpt

Article Last Updated: Oct 12, 2007